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ABSTRACT
Background and Objectives: Laparoscopic splenectomy
(LS) is now widely performed and is considered the stan-
dard of care for the treatment of certain diseases of the
spleen. Although multiple studies have documented the
safety and feasibility of laparoscopic splenectomy, little
long-term data are available. We present a 10-year, single
institution experience with laparoscopic splenectomy to
determine trends in procedural outcome data.
Methods: Laparoscopic splenectomy was performed in
109 consecutive, unselected patients with benign or ma-
lignant hematological diseases from March 1992 to No-
vember 2001. A prospective, longitudinal database, med-
ical record review, and patient interviews were used for
data acquisition. During the last 10-years, the annual num-
ber of laparoscopic splenectomy was relatively constant.
Therefore, patients were divided into 2 cohorts, compar-
ing the first 55 consecutive patients (Group I) with the
subsequent 54 patients (Group II) who underwent LS.
Data were analyzed using the unpaired Student t test, with
values of P0.05 considered significant.
Results: Mean patient age was 39 years (range, 6 to 79) in
Group I and 45 years (range, 13 to 77) in Group II. Total
operative time was 151 minutes in Group I and 159 min-
utes in Group II (NS), estimated blood loss averaged 544
mm in Group I and 308mm in Group II (P0.015). The
mean specimen weight of the spleen was 288 g in Group
I and 512 g in Group II (P0.03). Morbidity occurred in 7
of the first 55 patients (13%) and 5 of the next 54 patients
(9%). Additionally, 7 conversions to an open operation
were necessary in Group I (13%) versus only 1 conversion
in Group II (2%).
Conclusion: A decade of experience with LS shows that
it can be performed safely for a wide variety of indica-
tions. Over the last 10 years, the average spleen size has
increased, yet a significant reduction in blood loss and
conversion rate has been achieved.
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INTRODUCTION
Since Quittenbaum performed the first splenectomy in
1826, splenectomy has been performed for a variety of
hematological conditions.1 However, few changes in the
operative technique of splenectomy occurred until 1991,
when Delaitre and Maignien2 described their initial suc-
cess with laparoscopic splenectomy. Over the last decade,
laparoscopic splenectomy (LS) has grown from novelty to
the surgical procedure of choice for many diseases affect-
ing the spleen. The response rates of hematologic diseases
to LS are similar to those of historical controls who under-
went open splenectomy.3,4 Compared with open splenec-
tomy, however, LS is associated with decreased intraop-
erative blood loss, less postoperative pain, and a shorter
hospital stay.5–7
The first laparoscopic splenectomy at the University of
Maryland was performed in early 1992, shortly after De-
laitre and Maignien’s initial report. Little long-term peri-
operative data are available for LS, because few institu-
tions have performed the procedure for more than a few
years. We examined the 10-year, single-institution expe-
rience with LS at a university teaching hospital to deter-
mine trends in the operative technique, patient outcome,
and indications for laparoscopic splenectomy.
MATERIALS AND METHODS
Laparoscopic splenectomy has been performed at the
University of Maryland since March 1992. Since the incep-
tion of LS, all patients were enrolled in a prospective,
longitudinal database. Perioperative parameters were as-
sessed, including patient age and sex, surgical indication
for splenectomy, need for conversion to open splenec-
tomy, estimated blood loss, requirement for blood prod-
uct transfusion, spleen specimen weight, pre- and post-
operative hematocrit and platelet levels, time to oral
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SCIENTIFIC PAPERintake, length of hospital stay, and perioperative morbid-
ity or mortality. Additional information was obtained by
direct patient interview or review of medical records
when necessary.
Since the annual number of LS was relatively constant
during the 10-year study period, patients were arbitrarily
separated into 2 cohorts to study the effect of institutional
experience on outcome. The first consecutive 55 patients
(Group I) undergoing LS were compared with the subse-
quent 54 patients (Group II). The 2 groups were equally
matched with respect to age, sex, and indication for sple-
nectomy. Patient demographics are detailed in Table 1.
Preoperative preparation was individualized. All patients
received polyvalent Streptococcus pneumoniae vaccina-
tion before surgery. Some patients also received vaccina-
tion against Hemophilus influenzae. Transfusion of blood
products, such as platelets, packed red blood cells, or
gamma globulin, was performed at the discretion of the
referring hematologist, attending surgeon, or anesthesiol-
ogist. Routine preoperative imaging to determine splenic
size or the presence of accessory splenic tissue was not
performed. Preoperative angiographic embolization was
not used in any patient during the study.
The operative technique of LS evolved over the 10-year
period. The procedure was performed with the patient in
the supine position in the first 27 patients, the so-called
“anterior approach.”6 Gradual adoption of the lateral ap-
proach to LS occurred due to the institution’s large and
successful experience with laparoscopic donor nephrec-
tomy. The lateral approach to LS has been used exclu-
sively for the past 7 years.
Briefly, the patient is positioned in the right decubitus
position. Care is taken to ensure proper support and
padding of the patient’s head, neck, and lower extremi-
ties. Both the operating surgeon and camera operator
stand on the right side of the operating table. Three or 4
operating ports are placed after a pneumoperitoneum is
created (Figure 1). The initial 5-mm port (A) is placed
lateral to the rectus sheath approximately 1 cm to 2 cm
above the umbilicus. Port B (5 mm) is placed immediately
below the left costal margin in the midclavicular line, and
port C (15 mm) is placed 8 cm to 10 cm below the left
costal margin in the anterior axillary line. An additional
port (D, 5 mm) is often used to aid with retraction of the
splenic hilum or suctioning the operative field in cases
when significant splenomegaly is present. A 5-mm, 30-
degree, angled laparoscope is placed into port B, and the
operating surgeons left- and right-handed instruments are
inserted through port A and port C, respectively. The
operative dissection is determined to some extent by the
size, configuration, and consistency of the spleen, as well
as the indication for splenectomy. The first step is usually
a thorough search for accessory splenic tissue, focused on
the hilum, omentum, and lesser sac. Dissection generally
begins with division of the splenocolic attachments and
dissection of the medial aspect of the spleen in a cephalad
direction. The inferior pole splenic vessels are clipped or
divided with an ultrasonic scalpel. Blunt dissection on the
anterior and posterior aspects of the hilum is undertaken
to the extent the anatomy will allow. The hilar structures,
including the splenic artery and vein are ligated en masse
with an endoscopic linear stapler. The gastrosplenic liga-
ment and short gastric vessels are then divided using
either an ultrasonic scalpel or endoscopic linear stapler.
Finally, the lateral attachments of the spleen are divided,
and the spleen is placed into a large specimen retrieval sac
inserted through the 15-mm port. Extraction of the spleen
from the abdominal cavity is facilitated by use of a ringed
forceps or other clamp to fracture and morcellate the
specimen after the retrieval sac is partially exteriorized.
Table 1.
Patient Demographics
Group I Group II
Mean Age (years) 38 (6–79)* 44 (12–77)*
Male 24 (44%) 27 (50%)
Female 31 (56%) 27 (50%)
Benign Pathology 40 (73%) 30 (56%)
Malignant Pathology 15 (27%) 24 (44%)
*Range given in parentheses.
Figure 1. Patient positioning and typical port placement for the
lateral approach. Port A, Port B, and Port D (when necessary) are
5-mm ports, and Port C (used for specimen extraction) is a
15-mm port. (Reprinted with permission from the Archives of
Surgery 1999;134:1263–1269, Copyrighted 1999, American Med-
ical Association)
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excision.
Postoperatively, patients are monitored for pain control,
ability to resume oral intake, and the occurrence of com-
plications. The hematologic response to splenectomy is
also monitored, though it is usually too soon to determine
whether a positive therapeutic response to splenectomy
has occurred by the time of discharge. Patients are dis-
charged when they are fully able to tolerate a liquid diet
and their pain is adequately controlled with oral analge-
sics. All patients are followed in the surgeon’s office 10
days to 14 days after discharge.
RESULTS
From March 1992 to November 2001, LS was performed in
109 consecutive, unselected patients with benign or ma-
lignant hematological diseases. The indications for sple-
nectomy are listed in Table 2. Laparoscopic splenectomy
was successfully performed in 48 of 55 patients (87%) in
Group I and 53 of 54 patients (98%) in Group II. Conver-
sion to open splenectomy (Figure 2) occurred in 7of 55
patients (13%) in Group I and 1 of 54 patients (2%) in
Group II (P0.03). Excessive bleeding was the indication
for conversion of 6/7 patients in Group I and the single
conversion in Group II. An additional patient in Group I
with Hodgkin’s disease undergoing a staging procedure
required conversion to laparotomy. The laparoscopic pro-
cedure was converted to an open procedure to better
facilitate mesenteric and periaortic lymph node dissection.
Perioperative data are expressed in Table 3. Although the
mean operative time did not decrease over the years,
operative blood loss significantly decreased in patients in
Group I compared with those in Group II (P0.015).
Splenic specimen weight significantly increased over the
last decade. Mean specimen weight was 2884 4gi n
Group I and 51274 g in Group II (P0.03). No signifi-
cant difference existed between Groups I and II with
respect to time to resumption of oral intake or length of
hospital stay.
Postoperative morbidity was 13% in Group I and 9% in
Group II (Table 4). Perioperative arrhythmia necessitat-
ing intensive care unit monitoring occurred in 4 patients (2
from each group). Additional complications included left
lower lobe pneumonia (2 patients), superficial wound
Table 2.
Indication for Laparoscopic Splenectomy
Cause* Number Percentage
ITP 41 38
Hodgkin’s disease 12 11
Hypersplenism/Splenomegaly 12 11
AHA 9 8
CLL 8 7
CML 7 6
Lymphoma (other) 7 6
Splenic abscess 4 4
Splenic cyst 4 4
TTP 3 3
Metastatic melanoma 1 1
Hemangioma 1 1
*ITPidiopathic thrombocytopenic purpura, AHAautoimmune
hemolytic anemia, CLLchronic lymphocytic lymphoma,
CMLchronic myeloid leukemia, TTPthrombotic thrombocy-
topenic purpura.
Figure 2. The need for conversion of laparoscopic splenectomy
to open splenectomy has decreased with experience.
Table 3.
Perioperative Data*
Group I
(n55)
Group II
(n54)
P
Operating Room Time (min) 1517 15912 NS
Blood Loss (mL) 54473 30860 0.015
Spleen Weight (g) 28844 51274 0.03
Time to Intake by Mouth (h) 252.5 24.22.6 NS
Length of Stay (h) 10733 94.924 NS
*Results expressed as meanstandard error of mean.
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as no return of bowel function for 48 hours after sur-
gery), subphrenic abscess, and an abdominal wall hema-
toma at the extraction site. No significant difference ex-
isted in morbidity between Groups I and II.
Mortality occurred in 1/109 patient (1%), as a result of
overwhelming postsplenectomy infection (OPSI). The pa-
tient was a 33-year-old female who underwent LS in 1994
(Group I) for refractory thrombocytopenia of an uncertain
cause. Her past medical history was also significant for
primary pulmonary hypertension. She developed a fever
approximately 48 hours after an uneventful surgical pro-
cedure. Despite empiric broad-spectrum parenteral anti-
biotic therapy, clinical deterioration occurred with rapid
onset of anuria and refractory hypotension. She suc-
cumbed on postoperative day 8. The cause of death was
Staphylococcus aureus sepsis from a central venous cath-
eter introducer through which a pulmonary artery catheter
was placed for intraoperative hemodynamic monitoring.
DISCUSSION
Laparoscopic splenectomy has become the gold standard
for the elective treatment of many diseases of the spleen.
Although several studies document the safety and efficacy
of LS, no large, single-institution analysis has been per-
formed to date. Accordingly, several interesting observa-
tions can be drawn from this study.
Most importantly, LS was performed with acceptable mor-
bidity throughout the 10-year study period, despite the
unselected nature of the series and inclusion of patients
with significant comorbidities. The overall complication
rate was 11% for the entire series and only 9% over the last
5 years (Group II). The nature of the complications was
typical after splenectomy (wound infection, subphrenic
abscess, left-sided pulmonary complications), though the
incidence of arrhythmia was somewhat higher than antic-
ipated. These data compare favorably with data from the
largest series of LS published to date. Park examined 200
patients from 2 different institutions who underwent LS
from 1993 through 2000. Overall morbidity was 9.3%, and
no perioperative mortality occurred.8
The 1 death in this series deserves special attention. The
patient expired after a rapid, fulminant course of gram-
positive bacterial septicemia, a clinical picture very con-
sistent with overwhelming postsplenectomy infection
(OPSI). This is one of the first deaths from OPSI reported
after LS. The incidence of OPSI is typically quoted as
approximately 3.2%, with an overall mortality of 1.4%.9
However, the mortality rate is as high as 17% when bac-
teremia occurs in an asplenic individual in the immediate
postoperative period.10 Unfortunately, current data re-
garding the epidemiology of OPSI were generated during
the era of open splenectomy. It is not clear whether the
incidence of OPSI after LS in 2003 is equal to that after
open splenectomy from 1960 to 1990. Perioperative care
now includes widespread preoperative polymicrobial vac-
cination and improved antibiotic therapy. It is also not
clear whether the lesser insult to the immune system seen
after laparoscopic procedures translates into any clinical
benefit. Further study in this area is necessary. In any case,
it is important to realize that in asplenic individuals who
are immunized against Streptococcus pneumoniae, the
likelihood of identifying this pathogen as the cause of a
septic process is unlikely.10
Examination of intraoperative variables in this series re-
veals mixed results. A clear trend exists toward successful
performance of LS in patients with larger spleens, lower
blood loss, and acceptable morbidity. However, operative
times were not significantly improved over the 10-year
period. In addition, technical improvements did not seem
to result in earlier discharge from the hospital or more
rapid resumption of a diet. A number of possible expla-
nations exist for these observations.
Multiple factors influence the operative times during lapa-
roscopic splenectomy, including surgeon experience, in-
dication for the procedure, the presence of surgical train-
ees, and patient factors such as the presence of
coagulation defects or prior upper abdominal surgical
procedures. Examination of these variables may suggest
why the mean operative times did not decrease over the
last decade. First, referral patterns from surrounding he-
matologists changed over the 10-year period. As surgeons
and referring physicians gained confidence, patients with
Table 4.
Complications After Laparoscopic Splenectomy
Group I* Group II*
Postoperative arrhythmia (2) Postoperative arrhythmia (2)
Wound infection Wound infection
LLL pneumonia LLL pneumonia
Subphrenic abscess Abdominal wall hematoma
Ileus
Death (OPSI)
*LLLleft lower lobe, OPSIoverwhelming postsplenectomy
infection.
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conditions were seen. The number of LS performed for
idiopathic thrombocytopenic purpura (where spleen size
is usually normal) has dramatically decreased, whereas
the number of LS performed for secondary hypersplenism
and hematological malignancies has increased. Secondly,
operative times in teaching institutions tend to be cyclical.
During the early University of Maryland experience with
LS, 2 attending surgeons routinely performed the proce-
dure. Surgical fellows and residents enjoyed an increased
level of participation once the attending faculty had mas-
tered the technique. Though operative times are de-
creased by improved surgical instrumentation and attend-
ing surgeon experience, these improvements tend to be
offset by increased participation of trainees. Therefore,
operative times at teaching institutions are not likely to
change for the next several years.
Despite the fact that specimen weight in this series in-
creased over time, a concomitant decrease occurred in
operative blood loss. Reasons for this observation are
complex and include better instrumentation and operative
technique, and increased surgeon experience. Data dur-
ing open splenectomy suggest that spleen weight is di-
rectly proportional to blood loss.11 Operative data for LS in
patients with larger spleens is particularly interesting. The
average specimen in this series weighed 512 g (normal
splenic weight, 150 to 300) during the past 5 years. Several
specimens weighed more than 2000 g. Despite the in-
creased technical difficulty posed by splenomegaly, LS
was accomplished in a timely fashion in these patients
(mean operative time, 159 minutes), with minimal blood
loss (mean blood loss, 308 mL) and only 1 conversion to
open splenectomy. Kercher et al12 recently reported sim-
ilar results for LS in patients with massive splenomegaly.
In their series, “massive splenomegaly” was defined as
splenic weight greater than 600g. The mean operative
blood loss was 114 mL, mean operative time was 171
minutes, and no conversions to laparotomy were neces-
sary. When this same group of surgeons compared LS in
patients with splenomegaly (defined as splenic weight
greater than 500 g) to LS in patients with normal-sized
spleens, they noted longer operative times and increased
blood loss in patients with splenomegaly.13 A higher rate
of conversion did not occur in their patients with spleno-
megaly. However, Terrosu et al14 noted that when LS was
performed in patients with spleens larger than 2000 g, a
higher rate of conversion to laparotomy, an increased
amount of blood loss, and a longer hospital stay occurred
compared with LS performed in patients with smaller
spleens.
The declining rate of conversion of LS to open splenec-
tomy in this series is also multifactorial. Better equipment
is partially responsible by allowing less operative hemor-
rhage through improved hemostasis and less tissue
trauma during exposure and retraction. However, the in-
stitutional learning curve is probably the most important
factor. As attending surgeons gain experience with LS,
their operative decision-making and level of comfort is
improved. Previous studies have correlated the likelihood
of conversion of LS to open splenectomy with increasing
blood loss and spleen size.15 During the first 5 years of our
study, 13% of the procedures were converted to laparot-
omy, mostly due to excessive bleeding. However, over
the past 5 years, only 1 conversion has been necessary
(2%). Park8 noted a similar institutional trend. While his
overall conversion rate was 3%, over his last 160 proce-
dures, only 1.2% was converted to open splenectomy.
CONCLUSION
These data represent a decade of experience with LS,
which can be performed safely for a wide variety of
indications. Over the last 10 years, the average spleen size
has increased, yet a significant reduction in blood loss and
conversion rate has been achieved.
References:
1. McClusky DA, Skandalakis LJ, Colburn GL, Skandalakis JE.
Tribute to a triad: history of splenic anatomy, physiology, and
surgery—part 1. World J Surg. 1999;23:311–325.
2. Delaitre B, Maignien B. Laparoscopic splenectomy: one case
[letter]. Presse Med. 1991;44:2263.
3. Flowers JL, Lefor AT, Steers J, Heyman M, Graham SM,
Imbembo AL. Laparoscopic splenectomy in patients with hema-
tologic disease. Ann Surg. 1996;224:19–28.
4. Trias M, Targarona EM, Espert JJ, et al. Impact of hemato-
logical diagnosis on early and late outcome after laparoscopic
splenectomy. Surg Endosc. 2000;14:556–560.
5. Donini A, Baccarani U, Terrosu G, et al. Laparoscopic vs
open splenectomy in the management of hematologic diseases.
Surg Endosc. 1999;13:1220–1225.
6. Park A, Marcaccio M, Sternbach M, Witzke D, Fitzgerald P.
Laparoscopic vs open splenectomy. Arch Surg. 1999;134:1263–
1269.
7. Velanovich V, Shurafa MS. Clinical and quality of life out-
comes of laparoscopic and open splenectomy for haematologic
diseases. Eur J Surg. 2001;167:23–28.
8. Park AE, Birgisson G, Mastrangelo MJ, Marcaccio MJ, Witzke
JSLS (2005)9:163–168 167DB. Laparoscopic splenectomy: outcomes and lessons learned
from over 200 cases. Surgery. 2000;28:660–667.
9. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and
death among post-splenectomy patients. J Infect. 2001;43:182–
186.
10. Ejstrud P, Kristensen B, Hansen JB, Madsen KM, Schonhey-
der HC, Sorensen HT. Risk and patterns of bacteremia after
splenectomy: a population-based study. Scand J Infect Dis. 2000;
32:521–525.
11. Arnoletti JP, Karam J, Brodsky. Early postoperative compli-
cations of splenectomy for hematologic disease. Am J Clin On-
col. 1999;22:114–118.
12. Kercher KW, Matthews BD, Walsh RM, Sing RF, Backus CL,
Heniford BT. Laparoscopic splenectomy for massive splenomeg-
aly. Am J Surg. 2002;183:192–196.
13. Heniford BT, Park A, Walsh RM, et al. Laparoscopic sple-
nectomy in patients with normal-sized spleens versus spleno-
megaly: does size matter? Am Surg. 2001;67:854–857.
14. Terrosu G, Baccarani U, Bresadola V, Sistu MA, Uzzau A,
Bresadola F. The impact of splenic weight on laparoscopic
splenectomy. Surg Endosc. 2002;16:103–107.
15. Targarona EM, Espert JJ, Bombuy E, et al. Complications of
laparoscopic splenectomy. Arch Surg. 2000;135:1137–1140.
A Ten-year, Single Institution Experience With Laparoscopic Splenectomy, Bell RL et al.
JSLS (2005)9:163–168 168